NLRP3 inflammasome activation and altered mitophagy are key pathways in inclusion body myositis

Background: Inclusion body myositis (IBM) is the most prevalent muscle disease in adults for which no current treatment exists. The pathogenesis of IBM remains poorly defined. Inflammation and mitochondrial dysfunction are the most common histopathological findings. In this study, we aimed to explore the interplay between inflammation and mitochondrial dysfunction in IBM patients, highlighting sex differences. Methods: We included 38 IBM patients and 22 age- and sex-matched controls without myopathy. Bulk RNA sequencing, Meso Scale Discovery ELISA, western blotting, histochemistry and immunohistochemistry were performed on frozen muscle samples from the study participants. Results: We demonstrated activation of the NLRP3 inflammasome in IBM muscle samples, with the NLRP3 inflammasome pathway being the most upregulated. On muscle histopathology, there is increased NRLP3 immunoreactivity in both inflammatory cells and muscle fibers. Mitophagy is critical for removing damaged mitochondria and preventing the formation of a vicious cycle of mitochondrial dysfunction—NLRP3 activation. In the IBM muscle samples, we showed altered mitophagy, most significantly in males, with elevated levels of p-S65-Ubiquitin, a mitophagy marker. Furthermore, p-S65-Ubiquitin aggregates accumulated in muscle fibers that were mostly type 2 and devoid of cytochrome-c-oxidase reactivity. Type 2 muscle fibers are known to be more prone to mitochondrial dysfunction. NLRP3 RNA levels correlated with p-S65-Ubiquitin levels in both sexes but with loss of in muscle strength only in males. Finally, we identified sex-specific molecular pathways in IBM, with females having activation of pathways that could offset some of the pathomechanisms of IBM. Conclusions: NLRP3 inflammasome is activated in IBM, along with altered mitophagy particularly in males, which is of potential therapeutic significance. These findings suggest sex-specific mechanisms in IBM that warrant further investigation.

identified sex-specific molecular pathways in IBM, with females having activation of pathways that could offset some of the pathomechanisms of IBM.
Conclusions: NLRP3 inflammasome is activated in IBM, along with altered mitophagy particularly in males, which is of potential therapeutic significance.These findings suggest sexspecific mechanisms in IBM that warrant further investigation. .

Introduction:
Inclusion body myositis (IBM) is the most common muscle disease in aduls, for which there is no treatment. 1,2 t is characterized by relentlessly progressive muscle weakness, with decreased longevity and high morbidity as nearly all patients become wheelchair dependent as the disease progresses. 3,4 he pathomechanisms of IBM remain poorly understood posing major challenge for drug development.[10] In addition to the inflammatory reaction, IBM is characterized by the accumulation of autophagic vacuoles and protein deposition such as amyloid-β peptides, phosphorylated tau protein, p62 and TDP43. 11,12 s these features are similar to other diseases of aging such as Alzheimer's disease (AD) and Parkinson's disease (PD), IBM is also considered a degenerative disease by some. 13rthermore, the relationships among these various pathways remain poorly understood.
5][16] In addition, multiple mitochondrial DNA deletions occur in IBM muscles, with greater mutation load in CCO-negative fibers. 17,18 itochondrial dysfunction followed by endomysial inflammation are the two most commonly encountered histopathological features in IBM. 14,15 ever, a role for mitochondrial autophagy (mitophagy) in IBM has not been established thus far.The best characterized stress-induced mitophagy pathway is jointly directed by the ubiquitin .
(Ub) kinase PINK1 and the Ub E3 ligase PRKN (parkin). 19In damaged mitochondria, PINK1 builds up on the outer mitochondrial membrane (OMM), activating the PINK1-PRKN enzymatic pair. 20NK1 and PRKN then selectively decorate damaged mitochondria with phosphorylated (p-S65-) ubiquitin (Ub) chains that facilitate their degradation by the autophagy-lysosomal system. 21As such, the levels of p-S65-Ub are highly dynamic; they rise with the accumulation of p-S65-Ub up on damaged mitochondria, but then rapidly decline upon effective elimination of the organelles.
With the conundrum of involved pathways in IBM, systems biology approaches such as bulk transcriptomics analysis, are best suited as exploratory methods to study disease mechanisms.
][24][25][26][27][28] The strong expression of inflammation-related genes posed a challenge to the exploration of noninflammatory pathways, which are essential for understanding IBM pathogenesis.31] Hence, this study aimed to explore the interplay between mitochondrial dysfunction and inflammation in muscle tissue from male and female IBM patients, highlighting sex-specific differences.

Patient selection
A chart review of our electronic medical records was performed to identify IBM patients and controls.IBM diagnosis was established by fulfilling any category of the 2011 ENMC diagnostic .criteria. 32Controls were identified from the Muscle laboratory database searchable by diagnosis.Patients were included if they had documented normal strength, normal creatine kinase levels, no fibrillation potentials on electromyography, and no myopathy or inflammation on muscle biopsy.Controls underwent a muscle biopsy to rule out a muscle disorder and the workup was unremarkable.The IBM patients and controls were age and sex matched at a group level.Disease duration was defined as the time from symptom onset until biopsy.The manual muscle testing (MMT) score is a summated motor exam of bilateral shoulder abduction, elbow flexion, elbow extension, finger flexion, hip flexion, knee extension and ankle dorsiflexion.Each muscle is graded from 0 (normal) to 4 (complete paralysis) and the total score ranges from 0 (normal strength) to 56 (complete paralysis) as previously described. 33,34 MT was calculated at time of the biopsy.All muscle biopsies were originally obtained for clinical purposes per our clinical practice standards, and residuals were used for this project.After overnight fasting, an open biopsy was performed the following day in the operating room under conscious sedation.
The harvested muscle tissue was frozen in isopentane cooled in liquid nitrogen and stored at -80°C according to our Muscle laboratory protocols.

RNA extraction and sequencing
Approximately 20-30 mg of fresh frozen muscle tissue per sample were sent to GENEWIZ, LLC./Azenta US, Inc. (South Plainfield, NJ, USA) for RNA extraction and sequencing.Total RNA was extracted using Qiagen RNeasy Plus Universal kit following manufacturer's instructions (Qiagen, Hilden, Germany).Quantification was performed using Qubit 2.0 fluorometer (Thermo Fisher Scientific, Waltham, MA, USA) and RNA integrity was checked using TapeStation (Agilent Technologies, Palo Alto, CA, USA).All included samples had a RIN>6.The RNA sequencing library was prepared using the NEBNext Ultra II RNA Library Prep Kit for Illumina using manufacturer's instructions (New England Biolabs, Ipswich, MA, USA).The sequencing library was validated on the Agilent TapeStation (Agilent Technologies, Palo Alto, CA, USA), and quantified by using Qubit 2.0 fluorometer (Thermo Fisher Scientific, Waltham, MA, USA) as well as by quantitative PCR (KAPA Biosystems, Wilmington, MA, USA).The sequencing libraries were multiplexed and clustered across four flow cell lanes.After clustering, the flow cells were loaded onto the Illumina HiSeq instrument according to manufacturer's instructions.The samples were sequenced using a 2x150 bp paired-end (PE) configuration.Image analysis and base calling were conducted by the HiSeq Control Software (HCS).The raw sequence data (.bcl files) generated from Illumina HiSeq were converted into fastq files and demultiplexed using Illumina bcl2fastq 2.20 software.One mismatch was allowed for index sequence identification.

Transcriptomic data analysis
RNA sequencing data analysis was performed using Basepair software (https://www.basepairtech.com/) with a pipeline that included the following steps.The raw reads were trimmed using fastp to remove low-quality bases from the reads (quality < 10) and adapter sequences.Trimmed reads with a minimum length of 15 bp were aligned to the ENSEMBL GRCh38 genome assembly using STAR with default parameters. 35Alignments were sorted and indexed using samtools and normalized bigwig files were created for visualization using deepTools with a bin size of 5 bp.Read counts were collected at gene annotations using feature counts and data were visualized using the IGV browser.Differential expression analyses were performed using DESeq2.Pairwise comparisons were performed using the Wald test.The minimum gene expression cutoff was set at 10. Genes with fold change values greater than 1.5 (|log2 fold change| > 0.58) and a Benjamini-Hochberg adjusted p value ≤ 0.05 were considered DEGs.Analysis was performed on all IBM patients versus controls, male IBM patients versus male controls and female IBM patients versus female controls.Pathway enrichment analysis was carried out using the GSEA toolkit. 36,37 pearman rank correlation analysis was performed for NLRP3 against the whole dataset of IBM patients.To explore sex specific differences, we identified sex specific DEGs, defined as genes that were differentially expressed in one sex but not in the other, using the same cutoffs as described above.Genes with opposite trends were defined as those that were differentially expressed in both sexes but with opposite trends.

Protein lysate preparation
For protein lysate preparation, cell lysis buffer from Cell Signaling (Danvers, MA, USA, cat. #9803) supplemented with PMSF, phosphatase and protease inhibitors, and 10-20 mg of fresh frozen muscle tissue were added to a tube with metal beads.Homogenization was performed using a Fisherbrand bead homogenizer followed by sonication.Centrifugation followed in a refrigerated (4°C) Beckman centrifuge.For protein quantification, we used the DC protein assay (Bio-Rad) following the manufacturer's instructions.

P-S65-Ub measurement via Meso Scale Discovery-based sandwich ELISA
Sandwich ELISA targeting p-S65-Ub was performed via the Meso Scale Discovery (MSD) platform that uses electrochemiluminescence (ECL), as described previously. 38,39 riefly, 96-well plates (Meso Scale Diagnostics, L15XA-3) were coated overnight with 1 µg/ml capture p-S65-Ub antibody (Cell Signaling Technology, 62802) in 200 mM sodium carbonate buffer pH 9.7.MSD plates were washed twice with washing buffer (150 mM Tris, pH 7.4, 150 mM NaCl, 0.1% [v:v] Tween-20).Plates were then blocked with 1% BSA (w:v) in wash buffer for 1 hour.30 µg of samples were prepared in blocking buffer and incubated for 2 h.Detergent volumes were kept consistent across all samples and the samples were run in duplicates.

Statistical analysis
Continuous data are represented as mean (SD) or median (interquartile range) as appropriate, and categorical variables are represented as proportions and percentages.Statistical analysis was performed using BlueSky statistics v.7.10 software, GraphPad Prism v.9.3.1 and SAS 9.4 software (SAS Inc, Cary NC) unless otherwise stated (refer to the transcriptomics section for transcriptomic analysis details).Two-tailed Mann-Whitney test and Pearson or Spearman correlation were used as appropriate.

Data sharing statement
The Raw RNA sequencing data will be uploaded to a public database.Additional data supporting the findings of this study are available from the corresponding author upon reasonable request.

Study cohort characteristics
The study population consisted of 38 IBM patients and 22 controls without myopathy, with equal proportion of males and females in each group (Table 1).The mean age at biopsy was 62.9 years in the IBM group and 59.7 years in the control group.Mean disease duration at the time of biopsy in the IBM group was 6 years, and mean MMT score was 16.6.

Transcriptomic analysis of samples from IBM patients versus controls
To explore the molecular pathways involved in IBM pathogenesis, we first compared the IBM group to controls, including both males and females.Principal component analysis (PCA) revealed clear separation between the two groups (Figure 1A).There were 7448 differentially expressed genes (DEGs) in IBM: 5777 upregulated and 1671 downregulated (Figure 1A).A complete list of DEGs can be found in Supplemental Table 1.GSEA pathway analysis revealed that the NLRP3 inflammasome was the most upregulated pathway in IBM, followed by the interferon signaling pathway.Several of the top 10 downregulated pathways were related to mitochondria (the TCA cycle and respiratory electron transport, mitophagy and protein localization) (Figure 1B).To evaluate sex differences, we compared female IBM patients to female controls and male IBM patients to male controls.In females, there were 4743 upregulated and 1544 downregulated genes in IBM.In males, there were 4993 upregulated and 1623 downregulated genes in IBM.A complete list of DEGs in males and females can be found . in Supplemental Tables 2-3.We then identified sex-specific DEGs as shown in Figure 1C.There were 1754 female-specific and 2083 male-specific genes, and 2 genes with opposite trends between sexes.GSEA pathway analysis of sex-specific genes (Figure 1D) showed that the most upregulated female-specific pathways were related to the response to stress, defense response and regulation of the immune response.Whereas, the most upregulated male-specific pathways were related to cell adhesion, cell migration and the Fc receptors for IgG-dependent

NLRP3 inflammasome activation in inclusion body myositis
Next, we validated the overall highest upregulated pathway, the NLRP3 inflammasome, at the protein level in muscle samples from 16 IBM patients and 10 controls by western blotting.
There was increased expression of the two main NLRP3 inflammasome proteins: NLRP3 and ASC (apoptosis-associated speck-like protein containing CARD, also known as PYCARD: PYD and CARD Domain Containing) (Figure 2A).Upregulation of NLRP3-related genes and increased expression of NLRP3 and ASC proteins were observed in samples from both males and females.
Immunohistochemistry demonstrated increased NLRP3 immunoreactivity in both inflammatory cells and scattered muscle fibers (Figure 2B).Taken together, these data support that NLRP3 inflammasome is activated in IBM muscles consistent with the RNA-seq data.
The aberrant activation and regulation of the NLRP3 inflammasome are intricate and there is a growing body of literature elucidating its complexities. 44To better understand the related genes in our dataset, coexpression analysis of NLRP3 against all the other genes in the IBM dataset.

Altered mitophagy in muscle tissue from inclusion body myositis patients
Mitophagy was among the top 10 downregulated pathways in IBM in the combined male and female analysis, and mitophagy plays an important role in regulating inflammation in general and NLRP3 inflammasome activation in particular. 45To further explore whether mitophagy is altered in IBM muscles, we measured p-S65-Ub levels in muscle lysates from 22 IBM patients and 10 controls (Figure 3A).The level of p-S65-Ub was significantly greater in the IBM group compared to controls (p = 0.005), indicating altered mitophagy.This can be due to either stronger mitophagy initiation or lower mitophagic degradation in IBM skeletal muscle.Analysis by sex revealed that compared with male controls, IBM males had significantly greater level of p-S65-Ub (p = 0.014), whereas females only showed mild non-significant increase compared to female controls (p = 0.31).To further explore the distribution of the findings at the tissue level, we performed muscle enzymatic and immunohistochemical studies (Figure 3B-C).In muscle tissue from controls, type 2 fibers (fast twitch, lower mitochondrial content) had weak immunoreactivity to p-S65-Ub antibodies, while type 1 fibers (slow twitch, higher mitochondrial content) strongly reacted.This might reflect the difference in baseline mitophagy which is likely associated with the overall difference in mitochondrial content between fiber types.In contrast to samples from controls, there were p-S65-Ub positive aggregates in scattered muscle fibers in IBM muscles.These fibers were type 2 fibers that were also devoid of CCO activity (CCO negative fibers).Type 2 fibers are known to be more prone to mitochondrial failure. 46Also .noted, all CCO negative fibers, with or without observable p-S65-Ub aggregates, were type 2 fibers.These data suggest that mitophagy alterations occur mostly in type 2 fibers in IBM and are more significant in males.Additionally, several fibers with increased NLRP3 signal also exhibited increased p-S65-Ub immunoreactivity (Figure 3C), suggesting that these two pathways might be functionally associated.

Correlation of NLRP3 inflammasome activation with altered mitophagy and muscle weakness
We next determined whether the NLRP3 level or p-S65-Ub level was correlated with disease duration or disease severity, as reflected by the MMT score.The results are shown in Figure 4.
The NLRP3 level had a modest correlation with the p-S65-Ub level in both males and females (both sexes: correlation coefficient ρ = 0.41, males: ρ = 0.48, females: ρ = 0.54).NLRP3 levels strongly correlated with MMT scores in males (ρ = 0.62) but not in females (ρ = -0.14).Neither the NLRP3 nor the p-S65-Ub level correlated with disease duration.These findings further support the relationship between NLRP3 activation and altered mitophagy in IBM patients.Furthermore, NLRP3 activation is strongly associated with muscle weakness in males.

Discussion
Our study, for the first time, provides preliminary evidence that a vicious cycle of NLRP3 inflammasome activation and altered mitophagy exists in IBM muscles.Despite their intended protective role, aberrant activation of inflammasomes has been linked to the development of various chronic conditions, especially neurodegenerative diseases and other diseases of aging. 44,. 47The inflammasomes are supramolecular platforms for the activation of caspases through the release of proinflammatory cytokines IL-1β and IL-18, resulting in programmed cell death or apoptosis. 48NLRP3 remains the most studied inflammasome and has been implicated in the pathogenesis of many neurodegenerative diseases of aging such as AD, PD, and amyotrophic lateral sclerosis, but studies on its role in muscle disorders are limited. 44,47,49 I a recent study on IBM, Kummer et al. demonstrated increased NLRP3 mRNA levels by targeted qt-PCR in muscle tissue from IBM patients and postulated that NLRP3 may be a key driver of inflammation and protein accumulation in IBM. 50Herein, we demonstrated via unbiased analysis of transcriptomic data that the NLPR3 inflammasome pathway was indeed the most upregulated pathway in muscle tissue from both males and females with IBM with increased NLRP3 and ASC protein expression.The NLRP3 inflammasome belongs to the NOD-like receptor (NLR) signaling pathway which was the most significantly upregulated pathway in IBM muscle in a study by Murakami et al., validating our results. 27However, the authors did not provide further details on the mechanism of NLR signaling pathway and it was grouped under "infection pathways".
Similarly, the "neuroinflammation signaling pathway", which includes the NLRP3 inflammasome, was the most significantly upregulated pathway in IBM in a study by Pinal Fernandez et al. 24 It is noteworthy that correlation between histopathological and clinical characteristics is typically weak in IBM, given complexity of the disease and the heterogeneity of the IBM population. 33wever, we demonstrate strong correlation between the NLRP3 RNA level and the severity of muscle weakness, reflected by the MMT score, in males but not in females, supporting the clinical relevance of the activation of the NLRP3 inflammasome in IBM.
. Mitophagy serves to remove dysfunctional mitochondria via the autophagic machinery to maintain cellular homeostasis and mitochondrial integrity.While the PINK1-PRKN mitophagy pathway is genetically linked to PD, both proteins are expressed throughout the body and this pathway likely plays an important role beyond the brain.However, there are limited studies on mitophagy in human skeletal muscles.PRKN is thought to play an important role in the maintenance of mitochondrial integrity in skeletal muscles, and aging is associated with a decline in mitophagy, mitochondrial function and muscle mass. 51Herein, for the first time, we show robust alterations in the PINK1-PRKN mitophagy pathway in IBM.Elevated p-S65-Ub levels could stem from the accumulation of damaged mitochondria or from a block in the degradation of labeled mitochondria.Interestingly, the changes in p-S65-Ub were pronounced in males and more research is needed to determine sex-specific changes in PINK1-PRKN mitophagy mechanism(s).At the tissue level, altered mitophagy was observed in CCO-negative fibers.We also showed that loss of CCO activity and altered mitophagy both occur mainly in type 2 fibers.Type 2 fibers are more prone to mitochondrial failure because they have lower mitochondrial content and lower oxidative capacity being fast-twitch fibers that rely on glycolysis, and exhibit lower expression of E3 Ub-ligases and proteasome-mediated protein degradation. 46CCO negative fibers in IBM have also been shown to have increased mitochondrial DNA mutation loads. 16Moreover, the predilection of type 2 fibers also raises suspicion for underlying metabolic disturbances, which has not yet been fully explored in IBM.Lastly, unbiased coexpression analysis demonstrating that genes with strongest inverse correlation with NLRP3 level were mostly related to the mitochondria, immunohistochemical studies demonstrating abnormal p-S65-Ub aggregates in fibers with increased NLRP3 immunoreactivity, and the .correlation between the p-S65-Ub level and the NLRP3 level support that these pathways are functionally related in IBM.Based on these results, a vicious cycle of mitochondrial dysfunction/altered mitophagy and NLRP3 inflammasome activation is likely to occur in IBM (Figure 5).The release of mitochondrial damage-associated molecular patterns (DAMPs) such as mtDNA, cytochrome c, mitochondrial reactive oxygen species (ROS), and mitochondria-specific cardiolipin molecules, are known activators of the NLRP3 inflammasome. 44Under normal conditions, damaged mitochondria and the NRLP3 inflammasome are both removed by mitophagy and autophagy subsequently, reestablishing cellular homeostasis. 45,52 hen mitophagy and autophagy are altered, as in IBM, a feedforward loop is established. 45,53 reby, the inflammatory milieu results in additional oxidative stress and mitochondrial dysfunction with further release of mitochondrial DAMPs and subsequent aberrant NLRP3 inflammasome activation.This vicious self-sustaining cycle may be a major contributor to the chronic deterioration of muscle strength in individuals with IBM.Although not directly assessed in our study, the 26S proteasome and autophagy, the two major pathways for protein degradation in eukaryotic cells, have both been shown to be impaired in IBM. 54Additionally, decreased lysosomal proteolytic activity despite increased maturation of autophagosomes, as well as the upregulation and aggregation of chaperone-mediated autophagy components have been demonstrated in IBM muscles. 55,56 he accumulation of autophagic vacuoles and p62+ aggregates in muscle samples is used to aid in the histopathological diagnosis of IBM; p62 is a shuttle protein that transports polyubiquitinated proteins to either proteasomal or lysosomal degradation. 32,57 he original trigger for this self-sustained detrimental loop remains unclear.An aging skeletal milieu, with aging mitochondria and autophagic system, is probably required for .these events to occur given the age of the population at risk. 13Furthermore, antigen-driven inflammation at a preclinical stage preceding the activation of self-sustained inflammatory pathways that become nontargeted by conventional immunotherapies is possible.
Environmental and genetic risk factors could also be potential contributors to IBM pathogenesis. 58other major finding of this study is the demonstration of sex differences in IBM pathomechanisms.Male sex is a known risk factor for IBM as males are twice as likely to have the disease than females. 29,31 egarding disease severity, males are reported to have more significant limb weakness. 30Furthermore, additional variations in phenotype by sex have been described. 34Despite these phenotypic sex differences, none of the previous studies explored underlying differential disease mechanisms.In this study, we identified sex-specific genes and pathways that were differentially expressed only in one sex.Interestingly, the upregulated pathways in females could conceivably be protective likely indicating that females fared to respond better to stress and to the immune system activation, whereas in males, the upregulated pathways of cell adhesion and migration might have promoted disease pathogenesis.Increased expression of cell adhesion molecules, such as cadherin 1 has been reported in IBM. 28For downregulated sex-specific genes and related pathways, it is possible that females have decreased oxidative phosphorylation as a protection from oxidative stress, or as a result of lower mitochondrial mass from more preserved mitophagy.In contrast, pathways related to protein homeostasis and localization were downregulated in males.Disrupted protein homeostasis with the aggregation of autophagic vacuoles and misfolded protein aggregates is a canonical histopathological feature of IBM. 59,60 ast, males had more significantly altered .mitophagy than females, and NLRP3 levels correlated with the severity of muscle weakness in males supporting a direct association between NLPR3 activation and loss of muscle strength in this disease.Taken together, these observations shed light on potential mechanistic differences between sexes, possibly explaining, at least in part, why males are more commonly and severely affected in IBM, and offer solid hypotheses to be explored in future studies.
Limitations of this study include the retrospective nature of the chart review, and the lack of a valid disease model for IBM to further investigate the underlying pathomechanisms. 9The main strength of the study is that the experiments were performed on muscle samples from IBM patients providing insight into its pathogenesis.However, there is some heterogeneity inherent to the nature of the disease, stage of the disease at diagnosis, and muscle biopsy target.
The findings of this study may have major therapeutic implications.Small molecule mitochondria-targeted therapeutics are being investigated for the treatment of neurodegenerative diseases of aging. 61Intervening on mitochondrial pathways requires characterizing the specific level of mitochondrial dysfunction in a particular disorder. 62,63 5][66] Deciphering the intertwined nature of neurodegenerative diseases resulting in self-sustaining vicious cycles, such as those involving inflammasome activation and stalled mitophagy, has become of utmost importance, regardless of which is the cause versus the consequence.How to simultaneously target the various interwoven pathways involved in neurodegenerative diseases remains unknown and should be investigated in future studies.

Ethical statement
The study was approved by Mayo Clinic Institutional Review Board.The study was considered minimal risk; therefore, the requirement for informed consent was waived.However, records of any patient who had not provided authorization for their medical records to be used for research, as per Minnesota statute 144.335, were not reviewed.The use of fresh-frozen clinical residual muscle biopsy tissue was also approved by the Mayo Clinic Biospecimens Subcommittee.      .
phagocytosis.The most downregulated sex-specific pathways related to RNA metabolism and translation, and electron transport chain and oxidative phosphorylation in females, and protein localization, ubiquitination and degradation, and regulation of DNA repair in males.Only two genes had opposite trends (Figure1C): TPRG1 (Tumor Protein P63 Regulated 1) was upregulated in males and downregulated in females and TSPAN5 (Tetraspanin 5) was upregulated in females and downregulated in males.Information about the role of TPRG1 is sparse.TPRG1 promoted inflammation and activation of NF-КB signaling in a murine model of cystitis. 42TSPAN5 mediates signal transduction events that play a role in the regulation of cell development, migration and senescence.43

Figure 4 :
Figure 4: Correlation of NLRP3 inflammasome activation with altered mitophagy and muscle

Table 1 :
Baseline characteristics and patient demographics